




Searching News Database: Celgene
HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
HSMN NewsFeed - 13 Sep 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
HSMN NewsFeed - 3 Feb 2020
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
HSMN NewsFeed - 8 Jan 2020
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
HSMN NewsFeed - 6 Jan 2020
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
HSMN NewsFeed - 18 Sep 2019
BioTheryX, Inc. Announces the Appointment of Biopharma Veteran Jeffrey L. Edwards to Board of Directors
BioTheryX, Inc. Announces the Appointment of Biopharma Veteran Jeffrey L. Edwards to Board of Directors
HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
HSMN NewsFeed - 19 Jun 2019
HemoShear Therapeutics Names Biopharma Veteran Kathleen M. Metters, PhD, to Board of Directors
HemoShear Therapeutics Names Biopharma Veteran Kathleen M. Metters, PhD, to Board of Directors
HSMN NewsFeed - 11 Jun 2019
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
HSMN NewsFeed - 30 Apr 2019
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
HSMN NewsFeed - 13 Dec 2018
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 14 Aug 2018
Actavalon Announces Appointments of Dr. John Hood to Its Board of Directors
Actavalon Announces Appointments of Dr. John Hood to Its Board of Directors
HSMN NewsFeed - 30 Oct 2017
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
HSMN NewsFeed - 20 Oct 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
HSMN NewsFeed - 18 Sep 2017
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
HSMN NewsFeed - 17 Apr 2017
OncoMed’s Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints
OncoMed’s Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints
HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
HSMN NewsFeed - 27 Jan 2017
Juno Therapeutics Appoints Corsee D. Sanders as Executive Vice President and Head of Development Operations
Juno Therapeutics Appoints Corsee D. Sanders as Executive Vice President and Head of Development Operations
HSMN NewsFeed - 8 Dec 2016
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
HSMN NewsFeed - 29 Jun 2016
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
HSMN NewsFeed - 3 Mar 2016
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
HSMN NewsFeed - 8 Jan 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
HSMN NewsFeed - 19 Nov 2015
Triphase Accelerator Corporation Announces FDA Orphan Drug Designation for Marizomib in Malignant Glioma
Triphase Accelerator Corporation Announces FDA Orphan Drug Designation for Marizomib in Malignant Glioma
HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
HSMN NewsFeed - 10 Jun 2015
GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring
GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring
HSMN NewsFeed - 3 Jun 2015
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
HSMN NewsFeed - 18 Mar 2015
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
HSMN NewsFeed - 17 Oct 2014
Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer
Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
HSMN NewsFeed - 14 May 2014
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
HSMN NewsFeed - 24 Apr 2014
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders
HSMN NewsFeed - 10 Feb 2014
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 16 Oct 2013
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
HSMN NewsFeed - 23 Apr 2013
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
HSMN NewsFeed - 21 Feb 2013
ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team
ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team
HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
HSMN NewsFeed - 22 Jan 2013
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
HSMN NewsFeed - 3 Jan 2013
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
HSMN NewsFeed - 12 Oct 2012
FDA Approves ABRAXANE(R) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
FDA Approves ABRAXANE(R) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 25 Sep 2012
InspireMD Announces CEO Transition as it Sets Commercialization Plan for Advanced Stent Technology
InspireMD Announces CEO Transition as it Sets Commercialization Plan for Advanced Stent Technology
HSMN NewsFeed - 16 May 2012
Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer
Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer
HSMN NewsFeed - 27 Mar 2012
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
HSMN NewsFeed - 25 Aug 2011
Celsion Announces the Appointment of Gary Renshaw, D.O., as Executive Medical Director
Celsion Announces the Appointment of Gary Renshaw, D.O., as Executive Medical Director
HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
HSMN NewsFeed - 25 Aug 2009
Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
HSMN NewsFeed - 1 Jun 2009
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
HSMN NewsFeed - 21 Aug 2008
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
HSMN NewsFeed - 6 Aug 2008
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
HSMN NewsFeed - 13 Jun 2008
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
HSMN NewsFeed - 25 Mar 2008
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
HSMN NewsFeed - 19 Feb 2008
Lenalidomide (REVLIMID(R)) Receives Orphan Drug Status in Japan for Multiple Indications
Lenalidomide (REVLIMID(R)) Receives Orphan Drug Status in Japan for Multiple Indications
HSMN NewsFeed - 13 Sep 2007
PTC Therapeutics Announces $20 Million Strategic Investment From Celgene Corporation
PTC Therapeutics Announces $20 Million Strategic Investment From Celgene Corporation
HSMN NewsFeed - 19 Jun 2007
REVLIMID(R) Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
REVLIMID(R) Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
HSMN NewsFeed - 26 Oct 2006
NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
HSMN NewsFeed - 19 Sep 2006
QuantRx(R) Biomedical Appoints Former FDA Commissioner Dr. Arthur Hull Hayes, Jr. to Board of Directors
QuantRx(R) Biomedical Appoints Former FDA Commissioner Dr. Arthur Hull Hayes, Jr. to Board of Directors
HSMN NewsFeed - 29 Jun 2006
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of Multiple Myeloma
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of Multiple Myeloma
HSMN NewsFeed - 25 May 2006
Thalomid(R) sNDA Granted FDA Approval For Treatment of Newly Diagnosed Multiple Myeloma
Thalomid(R) sNDA Granted FDA Approval For Treatment of Newly Diagnosed Multiple Myeloma
Additional items found! 102

Members Archive contains
102 additional stories matching:
Celgene
(Password required)
Celgene
(Password required)